Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ObvioHealth has conducted over 42 studies in more than 17 therapeutic areas across 28 countries since its founding in 2017. Its decentralized clinical trial solutions have been used to support the development of new drugs and devices—including notable work on COVID‑19 outpatient studies—by enabling remote data capture and patient engagement through its proprietary digital platform. The company’s approach has demonstrated improved participant compliance and robust data collection for sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ObvioHealth.